Not applicableLooking for participantsNCT03796559What this trial is testingMagseed Enabled Long-Term Localization of Axillary Lymph NodesWho this might be right forBreast CancerAxillary Lymph Nodes Endomagnetics Ltd. 65
Not applicableUnknownNCT06097546What this trial is testingSerum Retinoic Acid Induced Protein 14 (RAI14) and Metastasis Associated Cancer Colon -1 (MACC-1) in Breast CancerWho this might be right forBreast Cancer Assiut University 90
Not applicableLooking for participantsNCT06727227What this trial is testingReal-world Study of Trastuzumab Deruxtecan in Patients With Unresectable or Metastatic HER2-low Breast CancerWho this might be right forBreast Cancer AstraZeneca 138
Testing effectiveness (Phase 2)Study completedNCT00900627What this trial is testingPhase I/II AZD8931/Paclitaxel in Treatment of Advanced Solid Tumours (Phase I) and Advanced Breast Cancer (Phase II)Who this might be right forNeoplasmsBreast NeoplasmsBreast Cancer AstraZeneca 330
Not applicableStudy completedNCT04047459What this trial is testingInvestigation of Cancer Cell Extravasation Through mRNA Analysis of Organ-specific Endothelial Cells and MicrofluidicsWho this might be right forBreast Cancer Metastatic I.R.C.C.S Ospedale Galeazzi-Sant'Ambrogio 31
Large-scale testing (Phase 3)Study completedNCT00075270What this trial is testingPaclitaxel With / Without GW572016 (Lapatinib) As First Line Therapy For Women With Advanced Or Metastatic Breast CancerWho this might be right forNeoplasms, Breast GlaxoSmithKline 580
Testing effectiveness (Phase 2)Study completedNCT00191854What this trial is testingGemcitabine Combinations in Metastatic Breast Cancer (MBC), 1st LineWho this might be right forBreast Cancer Eli Lilly and Company 147
Early research (Phase 1)Active Not RecruitingNCT06781983What this trial is testingSafety and Tolerability of IPH4502 in Patients With Advanced Solid TumorsWho this might be right forAdvanced or Metastatic Solid Tumors Innate Pharma 145
Not applicableLooking for participantsNCT06855654What this trial is testingPromoting Resilience in Women With Breast Cancer (PRISM -MBC)Who this might be right forBreast CancerMetastatic Breast Cancer UNC Lineberger Comprehensive Cancer Center 120
Post-approval studies (Phase 4)WithdrawnNCT02000739What this trial is testingGenetically-informed Therapies for Patients With Metastatic CancerWho this might be right forMetastatic Cancer Dartmouth-Hitchcock Medical Center
Testing effectiveness (Phase 2)Looking for participantsNCT05570253What this trial is testingSDX-7320 in Combination With Eribulin for People With Breast CancerWho this might be right forBreast CancerMetastatic Triple-Negative Breast Cancer Memorial Sloan Kettering Cancer Center 55
Early research (Phase 1)Ended earlyNCT02824575What this trial is testingRebastinib Plus Antitubulin Therapy With Paclitaxel or Eribulin in Metastatic Breast CancerWho this might be right forBreast CancerBreast AdenocarcinomaHuman Epidermal Growth Factor 2 Negative Carcinoma of Breast+2 more Montefiore Medical Center 28
Large-scale testing (Phase 3)Study completedNCT03462251What this trial is testingRibociclib and Endocrine Therapy or Chemotherapy With or Without Bevacizumab for Metastatic Breast Cancer in First LineWho this might be right forBreast CancerHormone Receptor Positive TumorHER 2 Negative Breast Cancer iOMEDICO AG 41
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07647029What this trial is testingA Clinical Study on Prophylactic RespOnse To hEtrombopag for Secondary Prevention in Anti-Cancer Therapy-induced ThrombocytopeniaeWho this might be right forBreast Cancer Patients at High Risk of Chemotherapy-induced Thrombocytopenia (CTIT) Fudan University 126
Large-scale testing (Phase 3)Study completedNCT05283837What this trial is testingEvaluate Safety, Efficacy, Pharmacokinetics, and Immunogenicity of Test Pertuzumab (ZRC-3277, Cadila Healthcare Ltd.,)Who this might be right forMetastatic Breast Cancer Zydus Lifesciences Limited 268
Not applicableStudy completedNCT02626039What this trial is testingCharacterization & Comparison of Drugable Mutations in Primary and Metastatic Tumors, CTCs and cfDNA in MBCpatientsWho this might be right forMetastatic Breast Cancer Hospital General Universitario Gregorio Marañon 40
Testing effectiveness (Phase 2)Study completedNCT00098605What this trial is testingLapatinib in Treating Brain Metastases in Patients With Stage IV Breast Cancer and Brain MetastasesWho this might be right forCentral Nervous System MetastasesHER2-positive Breast CancerMale Breast Cancer+3 more National Cancer Institute (NCI) 37
Not applicableStudy completedNCT03676257What this trial is testingSurvival Endpoints in Women Treated for Metastatic Breast Cancer: Contribution of Real-life DatabasesWho this might be right forMetastatic Breast Cancer Institut Bergonié 20,033
Not applicableEnded earlyNCT03073473What this trial is testingEvaluation of the NantHealth GPS Cancer Test in Patients With Advanced CancersWho this might be right forPancreatic CancerMetastatic Breast CancerMetastatic Lung Cancer+3 more Cota Inc. 40
Testing effectiveness (Phase 2)Study completedNCT02491983What this trial is testingPalbociclib in Combination With Fulvestrant or Letrozole in Patients With ER+, HER2- Advanced Breast CancerWho this might be right forMetastatic Breast Cancer MedSIR 486